(PharmaNewsWire.Com, July 31, 2019 ) Factors such as stringent regulatory guidelines in the pharmaceutical & biotechnology industry; expansion of the food and beverages industry; and increasing public-private investments in life science research are driving the market.
The global Reaction Monitoring market is expected to reach USD 1.52 Billion by 2022 from USD 1.09 Billion in 2016 at a CAGR of 5.7% during the forecast period.
+Market Dynamics
+ Drivers
+ Stringent Regulatory Guidelines in the Pharmaceutical & Biotechnology Industry
+ Expansion of the Food and Beverage Industry
+ Launch of Innovative Products
+ Increasing Public-Private Investments in Life Science Research
+ Increasing Government Support for Strengthening Pollution Monitoring and Control
The reaction monitoring market is segmented into spectroscopy, chromatography, X-ray diffraction, calorimetry, and titrimetry. The spectroscopy segment is expected to account for largest share of the reaction monitoing market in 2017. The large share of this segment can be attributed to the widespread use of spectroscopic techniques, increasing drug development pipelines, and stringent regulatory compliance for drug manufacturing & food processing protocols.
The reaction monitoring market is segmented into pharmaceutical, biopharmaceutical, and biotechnology companies, life science and genomic research facilities, food and beverage industry, pollution monitoring and control industry, and other end users. The pharmaceutical, biopharmaceutical, and biotechnology companies segment is estimated to command the largest share of the global reaction monitoring market in 2017.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
